May 27, 2021
FDA clears single-use flexible cystoscope from UroViu
Editor's Note
UroViu Corporation, Bellevue, Washington, announced May 24 that it has received clearance from the Food and Drug Administration (FDA) for its portable, flexible single-use cystoscope.
The Uro-G has a fully deflectable tip that enables physicians to perform interventional and diagnostic urologic procedures in various settings, without reprocessing.
Free Daily News
- Routine preop tests catch hidden risks in outpatient cosmetic surgery, Canadian study finds
- Study: Hospital same‑day knee replacements match ASC outcomes, even in higher‑risk patients
- FDA clears AI platform for real-time surgical measurements
- Study: MRI contrast agent causes harmful metal buildup in some patients
- Dissolvable pacemaker delivers temporary cardiac support without wires, surgery
- CSA taps Milagro’s AI coding to accelerate revenue cycle across ASC network
- Study: Cannabis use complicates sedation, cancer care
- Medication vial coring incidents prompt patient safety concerns
- First single-port robotic renal vein transposition surgery treats nutcracker syndrome
- Study: Mortality prediction models fail to recognize severe patient injuries
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement